New drugs for bad bugs: dual-functional therapies to treat resistant bacteria
In this project, my team is developing a new approach to tackling antimicrobial resistance that exploits alternate mechanisms to overcome bacterial infections through augmentation of host immune responses and removal of bacterial evasion mechanisms. Our simultaneous “drug-immune” therapies will provide highly synergistic bacterial killing utilising existing antibiotic therapeutics, thus underlining the feasibility of future clinical application of such approaches.
Edits to this research are currently being reviewed. If you want to update or request removal please email email@example.com.